AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced the election of two new members to its Board of Directors: Sam L. Barker, Ph.D., a founder of Clearview Projects, Inc. and former pharmaceutical industry executive at Bristol-Myers Squibb; and Margaret E. Grayson, President of AEP Government Solutions Group and Executive Vice President and General Manager of AEP Networks. Dr. Barker was appointed to serve on the Governance and Nominating Committee of the Board, and Ms. Grayson was appointed to serve on the Board's Audit Committee.
